- Home
- MXF vs TVRD Comparison
MXF vs TVRD Comparison
Compare MXF & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXF
- TVRD
- Stock Information
- Founded
- MXF 1981
- TVRD 2017
- Country
- MXF Mexico
- TVRD United States
- Employees
- MXF N/A
- TVRD N/A
- Industry
- MXF Trusts Except Educational Religious and Charitable
- TVRD Biotechnology: Pharmaceutical Preparations
- Sector
- MXF Finance
- TVRD Health Care
- Exchange
- MXF Nasdaq
- TVRD Nasdaq
- Market Cap
- MXF 276.4M
- TVRD 246.5M
- IPO Year
- MXF N/A
- TVRD N/A
- Fundamental
- Price
- MXF N/A
- TVRD $39.91
- Analyst Decision
- MXF
- TVRD Strong Buy
- Analyst Count
- MXF 0
- TVRD 5
- Target Price
- MXF N/A
- TVRD $59.20
- AVG Volume (30 Days)
- MXF 27.4K
- TVRD 68.2K
- Earning Date
- MXF 01-01-0001
- TVRD 11-21-2025
- Dividend Yield
- MXF 4.70%
- TVRD N/A
- EPS Growth
- MXF N/A
- TVRD N/A
- EPS
- MXF N/A
- TVRD N/A
- Revenue
- MXF N/A
- TVRD N/A
- Revenue This Year
- MXF N/A
- TVRD N/A
- Revenue Next Year
- MXF N/A
- TVRD N/A
- P/E Ratio
- MXF N/A
- TVRD N/A
- Revenue Growth
- MXF N/A
- TVRD N/A
- 52 Week Low
- MXF $14.77
- TVRD $8.13
- 52 Week High
- MXF $19.49
- TVRD $42.10
- Technical
- Relative Strength Index (RSI)
- MXF 44.01
- TVRD 68.51
- Support Level
- MXF $18.65
- TVRD $39.44
- Resistance Level
- MXF $19.86
- TVRD $42.10
- Average True Range (ATR)
- MXF 0.32
- TVRD 2.65
- MACD
- MXF -0.12
- TVRD 0.02
- Stochastic Oscillator
- MXF 1.31
- TVRD 75.13
About MXF Mexico Fund Inc. (The)
Mexico Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation. The fund seeks to achieve its objective through investment in securities, primary in equity, listed on the Mexican Stock Exchange. The company's portfolio of investments consists of investments in different sectors such as auto parts, airports, building materials, chemical products, consumer products, energy, food, and other sectors. The fund provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.